Synsam AB (publ) (SYNSAM.ST)
SEK 42.3
(0.83%)
SEK 42.3
(0.83%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 2.09 SEK | -4.57% |
| 2022 | 2.19 SEK | 544.12% |
| 2021 | 0.34 SEK | 126.15% |
| 2020 | -1.30 SEK | -9.24% |
| 2019 | -1.19 SEK | 40.5% |
| 2018 | -2.00 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.38 SEK | -7.32% |
| 2024 Q2 | 1.14 SEK | 200.0% |
| 2023 Q2 | 0.94 SEK | 623.08% |
| 2023 FY | - SEK | -4.57% |
| 2023 Q4 | 0.41 SEK | -31.67% |
| 2023 Q3 | 0.60 SEK | -36.17% |
| 2023 Q1 | 0.13 SEK | -61.76% |
| 2022 Q1 | 0.66 SEK | 112.9% |
| 2022 Q4 | 0.34 SEK | -35.85% |
| 2022 Q3 | 0.53 SEK | -18.46% |
| 2022 Q2 | 0.65 SEK | -1.52% |
| 2022 FY | - SEK | 544.12% |
| 2021 Q1 | -0.08 SEK | 82.98% |
| 2021 FY | - SEK | 126.15% |
| 2021 Q2 | 0.09 SEK | 216.63% |
| 2021 Q4 | 0.31 SEK | 2230.83% |
| 2021 Q3 | 0.01 SEK | -85.74% |
| 2020 FY | - SEK | -9.24% |
| 2020 Q3 | -0.35 SEK | 35.19% |
| 2020 Q1 | -0.95 SEK | 0.0% |
| 2020 Q4 | -0.47 SEK | -34.29% |
| 2020 Q2 | -0.54 SEK | 43.16% |
| 2019 FY | - SEK | 40.5% |
| 2018 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AddLife AB (publ) | 1.56 SEK | -33.974% |
| Biotage AB (publ) | 3.33 SEK | 37.237% |
| Bonesupport Holding AB (publ) | 3.77 SEK | 44.562% |
| Doxa AB (publ) | 0.60 SEK | -248.333% |
| Elekta AB (publ) | 3.41 SEK | 38.71% |
| iZafe Group AB (publ) | -0.14 SEK | 1592.857% |
| Ortivus AB (publ) | -0.41 SEK | 609.756% |
| Ortivus AB (publ) | -0.41 SEK | 609.756% |
| Q-linea AB (publ) | -3.48 SEK | 160.057% |
| S2Medical AB (publ) | -0.14 SEK | 1592.857% |